IOL Chemicals and Pharmaceuticals Ltd (IOLCP) has reported Consolidated financial results for the period ended June 30, 2025. 

IOLCP has posted net profit of Rs. 33.93 crores for the period ended June 30, 2025 as against net profit of Rs. 31.42 crores for the period ended March 31, 2025. The company posted net profit of Rs.29.97 crores for the period ended June 30, 2024. 

IOLCP has reported total income of Rs. 559.06 crores during the period ended June 30, 2025 as compared to Rs. 532.31 crores during the period ended March 31, 2025. The company reported total income of Rs. 509.76 crores during the period ended June 30, 2024. 

Key Business Updates for the Quarter 

Overseas Expansion: Formation of a wholly owned subsidiary in the United Kingdom to strengthen presence in the UK and EU markets and enable better customer access. 

New Project Announcement: The company has approved the establishment of Unit 9B, carved out from the existing Unit 9, dedicated to manufacturing Minoxidil and its intermediates. The unit will have an installed capacity of 120 MTPA, with a planned capital expenditure of ₹5.5 crore, fully funded through internal accruals. Completion is expected by December 2025.